Literature DB >> 17683249

Advanced delivery of ciclosporin A: present state and perspective.

Hongzhuo Liu1, Yongjun Wang, Sanming Li.   

Abstract

Ciclosporin A has been used as an immunosuppressor for organ transplantation and other autoimmune disorders for a number of years. Its poor biopharmaceutical characteristics of low solubility and permeability makes the uphill task of designing delivery systems even more challenging for the drug delivery scientist. Works have been performed to investigate administration through various body routes, and have employed approaches that use as emulsions, microspheres, nanoparticles, liposomes, physical and chemical penetration enhancers. Although progress has been made, there is still room for improvement in the application of ciclosporin A, as none of these formulations is ideal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683249     DOI: 10.1517/17425247.4.4.349

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  7 in total

Review 1.  Immunosuppressive and anti-inflammatory properties of engineered nanomaterials.

Authors:  A N Ilinskaya; M A Dobrovolskaia
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 2.  Malignant tumor-like gastric lesion due to Candida albicans in a diabetic patient treated with cyclosporin: a case report and review of the literature.

Authors:  Pasquale Mansueto; Giuseppe Pisciotta; Giovanni Tomasello; Daniela Cabibi; Aurelio Seidita; Alberto D'Alcamo; Angelo Maria Patti; Delia Sprini; Antonio Carroccio; Giovam Battista Rini; Gaetana Di Fede
Journal:  Clin Exp Med       Date:  2011-09-09       Impact factor: 3.984

Review 3.  Recent advances in ophthalmic drug delivery.

Authors:  Uday B Kompella; Rajendra S Kadam; Vincent H L Lee
Journal:  Ther Deliv       Date:  2010-09

Review 4.  New agents for treating dry eye syndrome.

Authors:  Simon E Skalicky; Con Petsoglou; Avinash Gurbaxani; Clare L Fraser; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

Review 5.  An overview on dry eye treatment: approaches for cyclosporin a delivery.

Authors:  Burçin Yavuz; Sibel Bozdağ Pehlivan; Nurşen Unlü
Journal:  ScientificWorldJournal       Date:  2012-04-24

Review 6.  Norine: A powerful resource for novel nonribosomal peptide discovery.

Authors:  M Pupin; Q Esmaeel; A Flissi; Y Dufresne; P Jacques; V Leclère
Journal:  Synth Syst Biotechnol       Date:  2016-06-01

Review 7.  Novel formulations for antimicrobial peptides.

Authors:  Ana Maria Carmona-Ribeiro; Letícia Dias de Melo Carrasco
Journal:  Int J Mol Sci       Date:  2014-10-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.